Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
, metabolomics, and mouse/cell culture models to understand the mechanisms underlying age-associated metabolic dysfunction. Qualifications for postdoc position: ⦁ PhD in Molecular Biology, Immunology
-
based at the Finnish Museum of Natural History LUOMUS at the University of Helsinki, Helsinki, Finland. The postdoctoral researcher will join the IsoMuseomics project , and work under the supervision
-
Postdoctoral Researcher in ML for Dynamical Systems Representation, Prediction, and State-estimation
cutting edge machine learning techniques for sequential data modelling, including Physics-informed Machine Learning and Koopman Operator-based representation framework, towards building interpretable
-
which Helsinki GSE collaborates, supporting knowledge-based decision-making. It produces up-to-date reports that make use of register data to support decision-making and to assess the impacts of policy
-
for your next career stage. Your profile Recent PhD in Cell Biology, Neuroscience, Biochemistry or a related discipline. A strong academic track record, and at least one recent first-author publication
-
Structures (FiRST). The starting date is March 1, 2026, or as mutually agreed. The positions are for a period of two years, with a possible one-year extension. Your experience We expect you to have a PhD
-
diverse backgrounds to apply for our positions. YOUR PROFILE PhD in statistics, mathematics, biology, evolutionary anthropology or a related field Strong background in statistical and mathematical modelling
-
in vivo genetic mouse models, advanced live and intravital imaging, engineered microchip models, primary cell co-culture systems and novel microscopy and analysis methods. The research will provide
-
and the services they provide. The successful candidate will play a key role in developing and applying economic models to assess impacts of biodiversity change on ecosystem service provision
-
biology, multiomics and single cell methodology to drive projects focusing on modelling leukemia and immune cell dynamics with the goal to develop new personalised medicine approaches. As our new